713-928-2355
Menu
  • Home
  • Practice Areas
    • Personal Injury and Dangerous Devices
      • Philips® CPAP Recall
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • 3M Earplug Lawsuit
    • Drug Injury
      • Purdue Opioid Claim
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Shingles Vaccine Lawsuit Zostavax®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
  • Maritime Injury
  • Buffalo Bayou or SJ River Claim
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
Home / Tag: Drug Injury

Tag: Drug Injury

  • Blog

Insomnia Drug May Cause Next Day Impairment

FDA Drug Safety Announcement — The U.S. Food and Drug Administration (FDA) is warning that the insomnia drug Lunesta (eszopiclone) can cause next-day impairment of driving and other activities that require alertness. As a result, we have...
  • More
  • 0
  • 0
  • 0
Posted May 16, 2014 | by victorlongo |in Uncategorized

Levaquin, Cipro, and More Required to Update Drug Labels and Medication Guides

The U.S. Food and Drug Administration (FDA) issued a safety alert stating that all fluoroquinolone antibacterial drugs must have updated drug labels and Medication Guides. List of Fluoroquinolone Drug Products The information currently missing...
  • More
  • 0
  • 0
  • 0
Posted August 16, 2013 | by victorlongo |in Uncategorized

FDA Warns of Rare Skin Reactions Associated with Acetaminophen

FDA Acetaminophen Warning The U.S. Food and Drug Administration released a Safety Communication warning that acetaminophen has been associated with the risk of a serious skin reaction.  The reaction, known as Stevens-Johnson Syndrome (SJS), toxic...
  • More
  • 0
  • 0
  • 0
Posted August 2, 2013 | by victorlongo

FDA Limits Usage of Nizoral Due to Liver Injury, Drug Interactions, and Adrenal Gland Problems

FDA Nizoral Safety Communication   The U.S. Food and Drug Administration issued a Drug Safety Communication describing new actions they are taking related to Nizoral oral tablets.  The agency warns that the drug can cause severe liver...
  • More
  • 0
  • 0
  • 0
Posted July 27, 2013 | by victorlongo |in Uncategorized

FDA Samsca Warning: Potential Risk of Liver Injury

The U.S. Food and Drug Administration released a Safety Announcement stating that the drug Samsca should not be used for longer than 30 days.  The announcement also said that the drug should not be used in patients with underlying liver disease...
  • More
  • 0
  • 0
  • 0
Posted June 5, 2013 | by victorlongo |in Uncategorized

Tainted Steroid Causes Fungus Meningitis

There have been more than 25 suspected cases of fungal meningitis reported in at lease five states. Fungal meningitis is a very serious illness. At least one of the cases resulted in death. The culprit is believed to be tainted steroid drugs. The...
  • More
  • 0
  • 0
  • 0
Posted October 24, 2012 | by victorlongo |in Uncategorized

FDA Combating Opioid Drug Abuse

The United States Food and Drug Administration (FDA) has announced a new risk reduction program targeting opioid drugs. Opioids are a prescription synthetic drug used to mitigate moderate to severe pain. Many of the opioids are made for use as...
  • More
  • 0
  • 0
  • 0
Posted August 3, 2012 | by victorlongo |in Uncategorized

GNC Moves Away From Ingredient DMAA

General Nutrition Center (GNC) announced it is getting away from dietary supplements containing the controversial ingredient DMAA. Steering away from DMAA products is a significant change for GNC in both marketing and advertising. The company had...
  • More
  • 0
  • 0
  • 0
Posted August 2, 2012 | by victorlongo

Takeda’s Successor Drug to Actos Fails to Win FDA Approval

Takeda Pharmaceutical Co. is Asia’s largest drug manufacturer and the maker of diabetes drugs. Takeda failed to win clearance to sell its new diabetes drug alogliptin in the United States. FDA regulators are asking for more information on the use...
  • More
  • 0
  • 0
  • 0
Posted July 11, 2012 | by victorlongo |in Uncategorized

Pradaxa Ranked as Most Reported Dangerous Drug in 2011

The Institute for Safe Medication Practices publishes the trademarked report QuarterWatch. ISMP analyzed direct reports of the U.S. Food and Drug Administration’s Adverse Event Reporting System (AERS) for 2011. The most frequently...
  • More
  • 0
  • 0
  • 0
Posted June 12, 2012 | by victorlongo |in Uncategorized

Pradaxa® Side Effects

Pradaxa® is a blood thinner primarily prescribed for those with atrial fibrillation, a heart rhythm disorder. Patients with atrial fibrillation have a higher risk of forming blood clots near the heart. Blood clots can travel through the body and...
  • More
  • 0
  • 0
  • 0
Posted March 2, 2012 | by victorlongo |in Uncategorized

Januvia® Study on Pancreatitis

The US Food and Drug Administration has sent a warning letter to Merck Sharp and Dohme Corp. (“Merck”) citing a violation of FDC Act § 505(o)(3). This type of warning letter, dated February 17, 2012, is part of the FDA’s new...
  • More
  • 0
  • 0
  • 0
Posted February 29, 2012 | by victorlongo
  • 1
  • 2
  • Next »
  • Last »

LikeBox

Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal